Browse
Explore conditions, clinical trials, and the organisations running them.
Never miss a new study
Get alerted when new trials match your condition
Sign up free to track the conditions you care about and get a personal digest when new trials appear.
By submitting, you agree to our Terms of use
127005 trials found · Page 797 of 6351
-
New drug combo aims to control Hard-to-Treat skin lymphoma
Disease control Recruiting nowThis is an open-label, single-arm, multicenter, phase II study combining pembrolizumab and mogamulizumab in patients with advanced-stage, relapsed or refractory CTCL Each cycle will equal 6 weeks. Pembrolizumab will be administered on Day 1 of each cycle. Mogamulizumab will be ad…
Phase 2 • Sponsor: University of Michigan Rogel Cancer Center • Aim: Disease control
Last updated Jun 27, 2026 12:28 UTC
-
New transplant method aims to cut dangerous immune reaction in half-matched donors
Disease control OngoingPatients with medical conditions requiring allogeneic hematopoietic cell transplantation (allo-HCT) are at risk of developing a condition called graft versus host disease (GvHD) which carries a high morbidity and mortality. This is a phase I/II study that will test the safety and…
Sponsor: Baylor College of Medicine • Aim: Disease control
Last updated Jun 27, 2026 07:56 UTC
-
Zapping stubborn cancer spots may extend life of current drug therapy
Disease control Recruiting nowThis is a phase 2 pragmatic study that evaluates the clinical benefit of continuing systemic therapy with the addition of locally ablative therapies for oligo-progressive solid tumors as the primary objective. The primary outcome measure is the time to treatment failure (defined …
Sponsor: University of California, Davis • Aim: Disease control
Last updated Jul 02, 2026 00:00 UTC
-
New drug under Real-World watch for tough stomach cancer
Disease control OngoingTrastuzumab deruxtecan (T-DXD) as monotherapy is indicated for the treatment of adult patients with advanced HER2-positive advanced gastric or gastroesophageal junction (GEJ) adenocarcinoma who have received a prior trastuzumab-based regimen. This study will assess the effective…
Sponsor: Daiichi Sankyo Europe, GmbH, a Daiichi Sankyo Company • Aim: Disease control
Last updated Aug 22, 2026 00:00 UTC
-
Liver cancer patients get immunotherapy before surgery in new trial
Disease control CompletedThis is a Phase Ib/II, open-label, multicenter, randomized platform study to evaluate neoadjuvant immunotherapy combinations in participants with resectable HCC. The study is designed with the flexibility to open new treatment arms as new agents become available, close existing t…
Phase 1/2 • Sponsor: Hoffmann-La Roche • Aim: Disease control
Last updated Jun 27, 2026 08:03 UTC
-
Could a nebulizer beat an inhaler for COPD symptom relief?
Disease control Recruiting nowThe purpose of this study is to compare the effectiveness of inhaled bronchodilators delivered via nebulizers vs. dry powder inhalers (DPIs) in symptomatic participants with Chronic Obstructive Pulmonary Disease (COPD) who have airflow obstruction (FEV1/FVC ≤ 70%) and show signif…
Phase 4 • Sponsor: University of Tennessee Graduate School of Medicine • Aim: Disease control
Last updated Aug 19, 2026 00:00 UTC
-
Which heat treatment shrinks thyroid nodules better?
Disease control Recruiting nowWe will conduct a multi-institutional randomized control trial of RFA and MWA for the primary treatment of large, benign nodules. Adult patients \>/=18 years of age who have a solitary thyroid nodule ≥20ml in volume who presents to 1) Columbia University, NY or 2) Queen Mary Hosp…
Sponsor: The University of Hong Kong • Aim: Disease control
Last updated Sep 06, 2026 00:00 UTC
-
Could a nutrient in eggs boost brainpower in starving kids?
Disease control OngoingThe goal of this clinical trial is to test adding choline to ready-to-use therapeutic food (RUTF) in children with severe acute malnutrition (SAM) in Malawi. The main question it aims to answer is: \- Will the addition of a 500mg daily dose of choline to RUTF during treatment fo…
Sponsor: Washington University School of Medicine • Aim: Disease control
Last updated Aug 15, 2026 00:00 UTC
-
New polio vaccine trial aims to protect the youngest
Vaccine Recruiting nowThe purpose of this clinical trial is to assess the safety and tolerability (primary objective), immunogenicity (primary and secondary objectives), fecal shedding of vaccine viruses (secondary objective) and the potential for neurovirulence of shed virus (secondary objective) of …
Phase 2 • Sponsor: PATH • Aim: Vaccine
Last updated Jun 27, 2026 12:31 UTC
-
AI reads chest X-Rays to catch lung cancer earlier
Diagnosis OngoingLung cancer is the most common cause of cancer death in the UK yet compared to Europe it has low survival rates.The NHS aims to find 75% of cancers at an early stage as this can improve the chances of survival. To support this target, Qure.ai have developed the UK-approved qXR p…
Sponsor: NHS Greater Glasgow and Clyde • Aim: Diagnosis
Last updated Jun 26, 2026 19:15 UTC
-
Firefighters' secret weapon against cancer? broccoli extract shows promise
Prevention OngoingThis phase II randomized, placebo-controlled trial evaluates whether daily supplementation with broccoli seed and sprout extract (BSSE), also known as Avmacol Extra Strength (ES), enhances the body's natural ability to detoxify carcinogens commonly encountered by firefighters. Fi…
Phase 2 • Sponsor: National Cancer Institute (NCI) • Aim: Prevention
Last updated Jun 27, 2026 12:32 UTC
-
New drug rosnilimab aims to tame ulcerative colitis in Mid-Stage trial
Disease control OngoingROSETTA STUDY: This study will evaluate the safety, tolerability, and efficacy of Rosnilimab in subjects with moderate to severe ulcerative colitis (UC)
Phase 2 • Sponsor: AnaptysBio, Inc. • Aim: Disease control
Last updated Jun 27, 2026 07:53 UTC
-
New drug aims to stop bile duct cancer from returning after surgery
Disease control OngoingA global study to assess the efficacy and tolerability of rilvegostomig compared to placebo in combination with investigator's choice of chemotherapy in participants with BTC after surgical resection with curative intent.
Phase 3 • Sponsor: AstraZeneca • Aim: Disease control
Last updated Jul 12, 2026 00:00 UTC
-
Drug combo shrinks kidney cancer clots before surgery in new trial
Disease control Recruiting nowThe primary objective of this study is to evaluate whether the combination of Pembrolizumab and Axitinib given in the neoadjuvant setting can change the Inferior Vena Cava Tumor Thrombus burden. A decrease in the size of the tumor thrombus can potentially lead to decrease in surg…
Phase 2 • Sponsor: University of Colorado, Denver • Aim: Disease control
Last updated Jun 27, 2026 12:06 UTC
-
Can airway cell clues predict a rare lung disease in children?
Knowledge-focused Recruiting nowBronchiolitis obliterans (BO) is an irreversible chronic obstructive pulmonary pathology leading to obstruction and/or obliteration of the small airways. In children, the most common form of BO occurs following a serious lower respiratory tract infection. This is a rare complicat…
Sponsor: Institut National de la Santé Et de la Recherche Médicale, France • Aim: Knowledge-focused
Last updated Aug 05, 2026 00:00 UTC
-
A balloon tube that could spare patients a stoma after bowel surgery
Disease control Recruiting nowThe purpose of this study is to evaluate the Colorectal Balloon Tube (hereinafter referred to as COLO-BT™) device, a single use, temporary intraluminal bypass device, intended to reduce contact of fecal content with an anastomotic site, following colorectal surgery (open or lapar…
Sponsor: JSR Medical Co., Ltd. • Aim: Disease control
Last updated Aug 07, 2026 00:00 UTC
-
Cooking up better diabetes control: can virtual classes teach teens healthier habits?
Disease control CompletedManaging T1D requires a demanding regimen to keep blood sugars in control and stay healthy. Despite recent advances, this remains extremely challenging for children and their families, who usually report having the most difficulty with the healthy eating aspect of the management,…
Sponsor: University of Pittsburgh • Aim: Disease control
Last updated Aug 23, 2026 00:00 UTC
-
Can ultrasound dye reveal spinal cord damage Mid-Surgery?
Diagnosis CompletedSpinal cord injury following posterior decompression in patients suffering from chronic, cervicothoracic spinal cord compression is a known complication with multiple etiologies. Currently, intraoperative neuromonitoring (IONM) remains the gold standard for predicting and prevent…
Sponsor: Medical University of South Carolina • Aim: Diagnosis
Last updated Sep 06, 2026 00:00 UTC
-
Could a TB vaccine stop diabetes? new trial hopes so
Prevention OngoingType 2 diabetes (T2D) will affect \~650 million adults worldwide by 2040 and about as many will have pre-diabetes. Chronic hyperinsulinemia/insulin resistance precedes T2D development. Studies link insulin resistance with chronic inflammation and oxidative stress. In Guinea-Biss…
Phase 4 • Sponsor: Bandim Health Project • Aim: Prevention
Last updated Jun 27, 2026 09:06 UTC
-
Knee ligament tear: can surgery outperform rehab alone?
Disease control Recruiting nowIsolated ruptures of the anterior cruciate ligament (ACL) can be proximal, distal or occur in the middle of the ACL. Treatment of patients with proximal lesions should be graded. Functional treatment can be reserved for low-demanding patients in whom the practice level is limite…
Sponsor: GCS Ramsay Santé pour l'Enseignement et la Recherche • Aim: Disease control
Last updated Aug 22, 2026 00:00 UTC